Position in INVA
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$248,288
-$6,450 QoQ
Shares Held
10,933
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#196
of 306 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAILARD, INC. holds $23,164,134 across 15 Biotechnology names. INVA ranks #5 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
37,314 | $18,534,983 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,376 | $2,105,071 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
1,400 | $442,526 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
6,277 | $295,270 | |
| 5 | INVA |
Innoviva, Inc.
This page
|
10,933 | $248,288 | |
| 6 | ERAS |
Erasca, Inc.
|
13,146 | $240,834 | |
| 7 | ZVRA |
Zevra Therapeutics, Inc.
|
14,700 | $210,798 | |
| 8 | ARTV |
Artiva Biotherapeutics, Inc.
|
20,700 | $200,790 |
All Filings in INVA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $248,288 | 10,933 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $254,738 | 10,933 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $218,550 | 10,933 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $190,548 | 10,441 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $209,598 | 10,433 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $189,150 | 10,433 | Shares | Sole | 2025-05-02 | |
| No filing history on record for this holder in this stock. | ||||||